Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke


Phase 1 Results N/A

Summary of Purpose

This is a open label study to assess the safety of autologous bone marrow transplantation in patients with a ischemic stroke in the middle cerebral artery territory within 90 days from symptoms onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 May 2011.

1 Dec 2005 10 May 2007 1 May 2011 1 May 2011 1 May 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


Not available